MMR mechanism, which is responsible for sustaining genome stability [14,15], consists of the following genes: MLH1, MSH2, MSH6, and PMS2, which have proven to hold a high clinical significance for MSI and genetic predisposition for CRC and PMS1 and MLH3 with less clear significance in CRC development [16]. This evidence concerns the gene MLH3 and colorectal carcinoma.